APOE and Parkinson disease: In contrast, variants in the APOE-gene were not associated with cognitive decline or dementia at 3.5, 5, or 10 year follow-up in the CamPaIGN study, a UK incident cohort of PD patients (7, 20), or with shorter time to dementia in another longitudinal study (41).